Healthcare -
Biotechnology - NASDAQ - US
$ 48.435
7.68 %
$ 3.15 B
Market Cap
-15.32
P/E
KYMR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KYMR - Kymera Therapeutics, Inc.
609 M
LAST VALUE
99.49%
2 YEAR CAGR
77.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR